18 studies found for:    " March 14, 2007":" April 13, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" March 14, 2007":" April 13, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (18 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed
Has Results
Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir
Conditions: HIV Infections;   AIDS Virus;   Human Immunodeficiency Virus;   Acquired Immunodeficiency Syndrome Virus
Intervention: Drug: darunavir (DRV, TMC114)
2 Terminated PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
Conditions: HIV-Dementia;   HIV-Associated Cognitive Motor Complex;   AIDS Encephalopathy;   AIDS Dementia Complex;   AIDS-Related Dementia Complex;   HIV Infections;   Healthy
Intervention: Drug: [11C]PBR28
3 Completed Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701
Conditions: HIV Infection;   Infection, Human Immunodeficiency Virus
Intervention: Procedure: Cheek swab & blood test
4 Completed
Has Results
HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults
Conditions: Infection, Human Immunodeficiency Virus I;   HIV-1 Infection
Intervention: Drug: fosamprenavir/ritonavir
5 Completed Botswana TDF/FTC Oral HIV Prophylaxis Trial
Condition: HIV Infections
Interventions: Drug: Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg;   Drug: TDF-FTC placebo
6 Active, not recruiting Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Placebo
7 Completed Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses
Condition: HIV Infections
Interventions: Drug: raltegravir potassium;   Drug: darunavir/ritonavir;   Drug: etravirine;   Drug: Optimized background regimen
8 Completed
Has Results
Treatment of Oral Warts in HIV+ Patients
Conditions: Papillomatosis;   HIV Infections
Interventions: Drug: Interferon-alpha;   Other: placebo
9 Completed Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products
Condition: HIV Infections
Intervention: Drug: nevirapine, stavudine, lamivudine
10 Completed Subclinical Atherosclerosis in HIV-infected Patients
Conditions: HIV Infections;   Coronary Atherosclerosis
Intervention:
11 Completed Mechanisms of Lipodystrophy in HIV-Infected Pateints
Condition: HIV Infections
Intervention: Drug: Viracept versus Sustiva with stavudine and epivir
12 Completed Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults
Condition: HIV Infections
Interventions: Drug: TRIZIVIR;   Drug: Non-nucleoside reverse transcriptase inhibitor;   Drug: Boosted Protease Inhibitor
13 Completed Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load
Condition: HIV Infections
Interventions: Drug: FTC/TDF + EFV or LPV/R +T20;   Drug: FTC/TDF + EFV or LPV/R
14 Unknown  Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2
Conditions: HIV Infections;   Hepatitis A;   Hepatitis B
Interventions: Biological: Twinrix;   Biological: interleukin-2
15 Completed
Has Results
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Conditions: HIV Infections;   Meningitis
Intervention: Biological: Quadrivalent meningococcal conjugate vaccine
16 Terminated
Has Results
Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation
Condition: HIV Infections
Interventions: Drug: tipranavir;   Drug: ritonavir
17 Completed CMV Disease and IRIS in HIV-1 Infected Persons
Conditions: HIV Infections;   Cytomegalovirus
Intervention: Genetic: IE gene
18 Completed
Has Results
Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.
Condition: HIV
Intervention: Drug: TMC125, Darunavir; Ritonavir

Indicates status has not been verified in more than two years